Market Tracker

08/27 6:05pm ET

Avanir Pharmaceuticals Inc (NASDAQ:AVNR)

During the Trading Day
6.05 -0.05 / -0.82%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
6.18 +0.1312 / +2.17%
 
Volume: 23.2K

Today’s Trading

Previous close6.10
Today’s open6.12
Day’s range5.95 - 6.23
Volume2,573,448
Average volume (3 months)2,038,960
Market cap$1.0B
Dividend yield--
Data as of 3:59pm ET, 08/27/2014

Growth & Valuation

Earnings growth (last year)-17.78%
Earnings growth (this year)+44.91%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+82.59%
P/E ratioNM
Price/Sales7.99
Price/Book50.22

Competitors

 Today’s
change
Today’s
% change
LGNDLigand Pharmaceutica...+0.18+0.35%
PTCTPTC Therapeutics Inc-0.33-1.02%
TSROTESARO Inc-1.17-3.74%
USNAUSANA Health Science...-0.73-0.98%
Data as of 4:02pm ET, 08/27/2014

Financials

Next reporting dateNovember 25, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$75.4M
Annual profit (last year)-$75.5M
Net profit margin-100.15%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Keith A. Katkin
Secretary &
Vice President-Finance
Christine G. Ocampo
Corporate headquarters
Aliso Viejo, California

Forecasts